EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multi-dimensional QSAR in drug research. Predicting binding affinities, toxicity and pharmacokinetic parameters



Multi-dimensional QSAR in drug research. Predicting binding affinities, toxicity and pharmacokinetic parameters



Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 55: 105-135



Quantitative structure-activity relationships (QSAR) are an area of computational research which builds atomistic or virtual models to predict the biological activity or the toxicity of known or hypothetical substances. Of particular interest for the biomedical sciences are three-dimensional receptor surrogates (3D-QSAR) because they allow for the simulation of directional forces such as hydrogen bonds or metal-ligand contacts--key interactions for both molecular recognition and stereospecific ligand binding. While more powerful approaches make use of a genetic algorithm or a neural network to evolve a receptor surrogate, its predictive power still critically depends on the spatial alignment of the ligand molecules--mirroring the pharmacophore hypothesis--used to construct it. To avoid this bias, a recent development at our laboratory includes the possibility to represent each ligand molecule by an ensemble of conformations, orientations and protonation states as the fourth dimension (4D-QSAR). In addition, it allows for a potentially flexible receptor site (mimicking local induced fit) and solvent-accessible or shallow binding pockets. In this account, we seek to document the superiority of 4D-QSAR compared to 3D-concepts with simulations on the steroid, the aryl hydrocarbon and the neurokinin-1 receptor system. More complex, future applications of 4D-QSAR--the establishment of a virtual laboratory for the assessment of receptor-mediated toxicity and the prediction of oral bioavailability--are outlined.

(PDF 0-2 workdays service: $29.90)

Accession: 035349106

Download citation: RISBibTeXText

PMID: 11127962



Related references

Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorganic & Medicinal Chemistry 17(2): 569-575, 2009

Modeling steric and electronic effects in 3D- and 4D-QSAR schemes: predicting benzoic pK(a) values and steroid CBG binding affinities. Journal of Chemical Information and Computer Sciences 43(6): 2081-2092, 2003

Multi-dimensional QSAR in drug discovery. Drug Discovery Today 12(23-24): 1013-1017, 2007

Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins. Journal of Medicinal Chemistry 42(22): 4650-4658, 1999

Side-chain conformational space analysis (SCSA): a multi conformation-based QSAR approach for modeling and prediction of protein-peptide binding affinities. Journal of Computer-Aided Molecular Design 23(3): 129-141, 2008

Docking-based three-dimensional quantitative structure-activity relationship (3D-QSAR) predicts binding affinities to aryl hydrocarbon receptor for polychlorinated dibenzodioxins, dibenzofurans, and biphenyls. Environmental Toxicology and Chemistry 32(7): 1453-1458, 2013

Recent advances in fragment-based QSAR and multi-dimensional QSAR methods. International Journal of Molecular Sciences 11(10): 3846-3866, 2010

Optimizing QSAR Models for Predicting Ligand Binding to the Drug-Metabolizing Cytochrome P45 Isoenzyme CYP2D6. 2011

Predicting isoform-specific binding selectivities of benzenesulfonamides using QSAR and 3D-QSAR. Current Computer-Aided Drug Design (): -, 2016

Structure-based drug design approaches for predicting binding affinities of HIV1 protease inhibitors. Journal of Enzyme Inhibition 14(1): 1-14, 1999

Re: QSAR models for predicting the acute toxicity of selected organic chemicals with diverse structures to aquatic non-vertebrates and humans. Calleja, M.C., Geladi, P., and Persoone, G. SAR QSAR Environ. Res. 2, 193-234. Sar and Qsar in Environmental Research 3(2): 151-159, 1995

A research to develop a predicting system of mammalian subacute toxicity: (1) Prediction of subacute toxicity using the biological parameters of acute toxicities. Chemosphere 32(5): 979-998, 1996

Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humans. Stem Cell Research & Therapy 4 Suppl 1: S16-S16, 2014